Records containing: Melanoma
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2020-08-20Phase 2 Trial of SAbR Plus Ipilimumab Plus Nivolumab in Metastatic Melanoma Patients
-
CLINICAL_TRIALS study record update · 2020-08-20Safety and Efficacy of Blood Brain Barrier Opening With Implantable Device Sonocloud® Combined With Nivolumab Used Alone or an Association With Ipilimumab in Brain Metastases From Patients With Malignant Melanoma
-
CLINICAL_TRIALS study record update · 2020-08-10Development of BioForte Technology for in Silico Identification of Valuable Genomic Features That Are Candidates for Microbiome-based Therapeutics and Diagnostics.
-
CLINICAL_TRIALS study record update · 2020-08-10An Open-Label, Phase 1, Dose Escalation Study of MLN2480 in Patients With Relapsed or Refractory Solid Tumors Followed by a Dose Expansion Phase in Patients With Metastatic Melanoma
-
CLINICAL_TRIALS study record update · 2020-08-03A Phase I Trial Testing Mart-1 Peptide Immunization in Malignant Melanoma
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2020-07-30Molecular Characterisation of Serial Tumour Samples and Their Correlation With Circulating Biomarkers and Other Biospecimens Taken During the Clinical Course of Patients Receiving Treatment for Malignant Melanoma.
-
CLINICAL_TRIALS study record update · 2020-07-20Study of CD160, an Activating NK Cell Receptor, in Melanoma: a Potential Therapeutic Target?
-
CLINICAL_TRIALS study record update · 2020-07-15Nurses' Health Study and Health Professionals Follow-Up Study (Dermatological Component)
-
CLINICAL_TRIALS study record update · 2020-07-07A Phase 1b Trial of X4P-001 Alone and With Pembrolizumab in Patients With Advanced Melanoma
-
CLINICAL_TRIALS study record update · 2020-07-01A Phase 1b Study Evaluating the Safety, Tolerability and Immunogenicity of CMB305 (Sequentially Administered LV305 and G305) in Patients With Locally Advanced, Relapsed, or Metastatic Cancer Expressing NY-ESO-1
-
CLINICAL_TRIALS study record update · 2020-07-01Family Study of Melanoma in Italy
-
CLINICAL_TRIALS study record update · 2020-06-30Molecular Epidemiology of Cutaneous Malignant Melanoma
-
CLINICAL_TRIALS study record update · 2020-06-18Vaccination of Patients With Stage III or IV Malignant Melanoma With Melanoma Antigen Peptides [Melan-A/Mart-1 Analog (ELA), NY-ESO-1b(A) Analog and MAGE-A10] and Montanide Adjuvant
-
CLINICAL_TRIALS study record update · 2020-06-09Sentinel Node and Non-Sentinel Lymph Nodes (SLN and Non-SLN) Procurement From Melanoma Subjects for Molecular Profiling Analysis
-
CLINICAL_TRIALS study record update · 2020-05-29A Phase I Trial of Vemurafenib and Hydroxychloroquine in Patients With Advanced BRAF Mutant Melanoma
-
CLINICAL_TRIALS study record update · 2020-05-28A Phase I Study of Indoximod [1-methyl-D-tryptophan (D-1MT)] in Patients With Relapsed or Refractory Solid Tumors
-
CLINICAL_TRIALS study record update · 2020-05-26A Phase 2 Trial of Adjuvant Dabrafenib (GSK2118436) in Patients With Surgically Resected AJCC Stage IIIC Melanoma Characterized by a BRAFV600E/K Mutation
-
CLINICAL_TRIALS study record update · 2020-05-21Camrelizumab Plus Apatinib and Temozolomide as First Line Therapy in Advanced Acral Melanoma：a Single-center, Exploratory Clinical Study
-
CLINICAL_TRIALS study record update · 2020-05-21A Phase 1b Study of the Selective HDAC Inhibitor Mocetinostat in Combination With Ipilimumab and Nivolumab in Patients With Unresectable Stage III or Stage IV Melanoma
-
CLINICAL_TRIALS study record update · 2020-05-20Study of CDX-3379, a Human Monoclonal Antibody Targeting ERBB3, in Combination With the MEK Inhibitor, Trametinib, in Patients With Advanced Stage NRAS Mutant and BRAF/NRAS Wildtype (WT) Melanoma
-
CLINICAL_TRIALS study record update · 2020-05-19A Randomized, Open-Label, Two-arm, Comparative Study in Chinese Subjects With Chemotherapy Naïve Stage IV Melanoma Receiving Ipilimumab (3 mg/kg) vs. Dacarbazine
-
CLINICAL_TRIALS study record update · 2020-05-12A Phase 1, Open-label, Multicenter, Randomized, 2-Period, Crossover Study to Evaluate the Bioequivalence and Food Effect Bioavailability of CC-486 (Oral Azacitidine) Tablets in Adult Cancer Subjects
-
CLINICAL_TRIALS study record update · 2020-05-05Spanish Registry of Mohs Surgery [Registro Español de Cirugía de Mohs]
-
CLINICAL_TRIALS study record update · 2020-05-01A Phase 1 Dose Escalation Study of the Safety, Tolerability, and Pharmacokinetics of Ipilimumab in Chinese Subjects With Select Advanced Solid Tumors
-
CLINICAL_TRIALS study record update · 2020-04-30Phase II Trial of Outpatient Intravenous Interleukin-2 in Malignant Melanoma and Metastatic Kidney Cancer